Lucid Diagnostics (LUCD) Depreciation & Amortization (CF) (2021 - 2026)
Lucid Diagnostics (LUCD) posted Depreciation & Amortization (CF) of $222000.0 for Q1 2026, up 6.22% on a QoQ basis from $209000.0 in Q4 2025, and little changed year-over-year from $221000.0 in Q1 2025.
Lucid Diagnostics (LUCD) Depreciation & Amortization (CF) (2021 - 2026) Analysis & Trends
Lucid Diagnostics' Depreciation & Amortization (CF) history runs 6 years deep, the most recent figure standing at $222000.0 for Q1 2026.
- Quarterly Depreciation & Amortization (CF) changed 0.45% year-over-year to $222000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $873000.0 (down 1.58% YoY) and the FY2025 annual result came in at $872000.0, down 25.28% from the prior year.
- Depreciation & Amortization (CF) was $222000.0 for Q1 2026 at Lucid Diagnostics, up from $209000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $704000.0 in Q2 2022 and bottomed at $24000.0 in Q1 2022.
- A 5-year average of $393882.4 and a median of $229000.0 in 2024 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) soared 61400.0% — and 2024, when it plunged 65.6%.
- Lucid Diagnostics' Depreciation & Amortization (CF) stood at $615000.0 in 2022, then gained by 2.28% to $629000.0 in 2023, then slumped by 64.71% to $222000.0 in 2024, then decreased by 5.86% to $209000.0 in 2025, then gained by 6.22% to $222000.0 in 2026.
- Business Quant data shows LUCD's Depreciation & Amortization (CF) at $222000.0 in Q1 2026, $209000.0 in Q4 2025, and $220000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 67.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 310.25 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Lucid Diagnostics | 133.09 Mn | 105.22 Mn | -325,000.00 | 222,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 222,000.00 |
| Mar 31, 2026 | 222,000.00 |
| Dec 31, 2025 | 209,000.00 |
| Dec 31, 2025 | 209,000.00 |
| Sep 30, 2025 | 220,000.00 |
| Sep 30, 2025 | 220,000.00 |
| Jun 30, 2025 | 222,000.00 |
| Jun 30, 2025 | 222,000.00 |
| Mar 31, 2025 | 221,000.00 |
| Mar 31, 2025 | 221,000.00 |
| Dec 31, 2024 | 222,000.00 |
| Dec 31, 2024 | 222,000.00 |
| Sep 30, 2024 | 215,000.00 |
| Sep 30, 2024 | 215,000.00 |
| Jun 30, 2024 | 229,000.00 |
| Jun 30, 2024 | 229,000.00 |
| Mar 31, 2024 | 501,000.00 |
| Mar 31, 2024 | 501,000.00 |
| Dec 31, 2023 | 629,000.00 |
| Dec 31, 2023 | 629,000.00 |